Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 EX-3.1 Amendment to the Registrant's Certificate of Incorporation, Effecting a 10-TO-1 Reverse Stock Split of Critical Therapeutics, Inc.'s Common Stock.
- 3.2 EX-3.2 Amendment to the Registrant's Certificate of Incorporation, Changing the Name of the Corporation from Critical Therapeutics, Inc. to Cornerstone Therapeutics Inc.
- 4.1 EX-4.1 Form of the Registrant's Stock Certificate
- 10.1 EX-10.1 Agreement Between Patheon, Inc. (Formerly Known As Mova Pharmaceutical Corporation) and Cornerstone Biopharma, Inc. Dated August 8, 2007
- 10.2 EX-10.2 Change of Scope Agreement Between Patheon, Inc. (Formerly Known As Mova Pharmaceutical Corporation) and Cornerstone Biopharma, Inc. Dated November 20, 2007
- 10.3 EX-10.3 Copromotion Agreement Between Atley Pharmaceuticals, Inc. and Cornerstone Biopharma, Inc. Dated April 2, 2007
- 10.4 EX-10.4 First Amendment, Dated July 1, 2008, to Copromotion Agreement Between Atley Pharmaceuticals, Inc. and Cornerstone Biopharma, Inc. Dated April 2, 2007
- 10.5 EX-10.5 Manufacturing Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc. (Formerly Known As Cornerstone Pharmaceuticals, Inc.) Dated July 20, 2004
- 10.6 EX-10.6 License and Supply Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated October 12, 2006
- 10.7 EX-10.7 Amendment No. 1, Dated July 27, 2007, to License and Supply Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated October 12, 2006
- 10.8 EX-10.8 Letter Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated July 27, 2007
- 10.9 EX-10.9 Formulation Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated January 11, 2008
- 10.10 EX-10.10 Addendum, Dated August 14, 2008, to License and Supply Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated October 12, 2006
- 10.11 EX-10.11 Joint Development Agreement Between Meiji Seika Kaisha, LTD. and Cornerstone Biopharma, Inc. Dated February 11, 2008
- 10.12 EX-10.12 Patent License Agreement Between Pharmaceutical Innovations, LLC and Cornerstone Biopharma, Inc. Effective As of August 31, 2006
- 10.13 EX-10.13 Amendment No. 1, Dated August 10, 2007, to Patent License Agreement Between Pharmaceutical Innovations, LLC and Cornerstone Biopharma, Inc. Effective As of August 31, 2006
- 10.14 EX-10.14 Amendment No. 2, Dated February 15, 2008, to Patent License Agreement Between Pharmaceutical Innovations, LLC and Cornerstone Biopharma, Inc. Effective As of August 31, 2006
- 10.15 EX-10.15 Development, License and Services Agreement Between Neos Therapeutics, L.P. and Cornerstone Biopharma, Inc. Dated March 19, 2008
- 10.16 EX-10.16 Development and Manufacturing Agreement by and Among Neos Therapeutics, L.P., Coating Place, Inc. and Cornerstone Biopharma, Inc. Effective February 27, 2008
- 10.17 EX-10.17 Products Development Agreement Between Neos Therapeutics, L.P. and Cornerstone Biopharma, Inc. Dated August 27, 2008
- 10.18 EX-10.18 Supply and Marketing Agreement Between Sovereign Pharmaceuticals, LTD and Aristos Pharmaceuticals, Inc. Dated May 1, 2008
- 10.19 EX-10.19 Asset Purchase Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc. (As Assignee of Cornerstone Biopharma, LTD. (Formerly Known As Cornerstone Pharmaceuticals LTD.)
- 10.20 EX-10.20 Amendment No. 1, Dated May 20, 2005, to Asset Purchase Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc. (As Assignee of Cornerstone Biopharma LTD.
- 10.21 EX-10.21 Amendment No. 2, Dated November 16, 2005, to Asset Purchase Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc.
- 10.22 EX-10.22 Amendment No. 2, Dated November 13, 2006, to Asset Purchase Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc.
- 10.23 EX-10.23 Amendment No. 3, Dated December 7, 2006, to Asset Purchase Agreement Between Vintage Pharmaceuticals, LLC and Cornerstone Biopharma, Inc.
- 10.24 EX-10.24 Lease Agreement Between Regency Park Corporation and Cornerstone Biopharma, Inc. Dated August 11, 2004
- 10.25 EX-10.25 Addendum No. 1, Dated January 18, 2005, to Lease Agreement Between Regency Park Corporation and Cornerstone Biopharma, Inc. Dated August 11, 2004
- 10.26 EX-10.26 Lease Agreement Between Crescent Lakeside, LLC and Cornerstone Biopharma Holdings, Inc. Dated May 1, 2008
- 10.27 EX-10.27 Executive Employment Agreement Between Cornerstone Biopharma, Inc. and Craig A. Collard Dated March 1, 2006
- 10.28 EX-10.28 Executive Retention Agreement Between Cornerstone Biopharma, Inc. and Craig A. Collard Dated February 8, 2006
- 10.29 EX-10.29 Executive Employment Agreement Between Cornerstone Biopharma, Inc. and Chenyqua Baldwin Dated March 1, 2006
- 10.30 EX-10.30 Executive Employment Agreement Between Cornerstone Biopharma, Inc. and Brian Dickson Dated March 1, 2006
- 10.31 EX-10.31 Agreement Regarding Employment, Employee Duties, Ownership of Employee Developments, and Confidentiality Between Cornerstone Biopharma, Inc. and George Esgro Dated March 3, 2008
- 10.32 EX-10.32 Executive Employment Agreement Between Cornerstone Biopharma, Inc. and Steven Lutz Dated March 1, 2006
- 10.33 EX-10.33 Executive Employment Agreement Between Cornerstone Biopharma Holdings, Inc. and David Price Dated August 20, 2008
- 10.34 EX-10.34 Amended and Restated Restricted Stock Agreement Between Cornerstone Biopharma Holdings, Inc. and David Price Dated October 31, 2008
- 10.35 EX-10.35 Form of Proprietary Information, Inventions, Non-competition and Non-solicitation Agreement
- 10.36 EX-10.36 Form of Indemnification Agreement, Entered into Between Cornerstone Biopharma Holdings, Inc. and Each of Craig Collard and Alastair Mcewan
- 10.37 EX-10.37 Cornerstone Biopharma Holdings, Inc. 2005 Stock Incentive Plan (As Amended and Restated Effective October 31, 2008)
- 10.38 EX-10.38 Cornerstone Biopharma Holdings, Inc. 2005 Stock Option Plan (As Amended and Restated Effective October 31, 2008)
- 10.39 EX-10.39 Form of Nonstatutory Stock Option Agreement Granted Under the 2005 Stock Incentive Plan
- 10.40 EX-10.40 Form of Nonstatutory Employee Stock Option Agreement Granted Under the 2005 Stock Option Plan
- 10.41 EX-10.41 Commercial Note Issued by Cornerstone Biopharma Holdings, Inc. to Paragon Commercial Bank Dated April 21, 2005
- 10.42 EX-10.42 Security Agreement by Cornerstone Biopharma Holdings, Inc. In Favor of Paragon Commercial Bank Dated April 21, 2005
- 10.43 EX-10.43 Modification Agreement, Dated April 10, 2006
- 10.44 EX-10.44 Modification Agreement, Dated July 31, 2007
- 10.45 EX-10.45 Letter Agreement, Dated June 23, 2008
- 10.46 EX-10.46 Modification Agreement, Dated June 25, 2008
- 10.47 EX-10.47 Unconditional Guaranty by Cornerstone Biopharma, Inc. In Favor Paragon Commercial Bank Dated June 25, 2008
- 10.48 EX-10.48 Security Agreement by Cornerstone Biopharma, Inc. and Cornerstone Biopharma Holdings, Inc. In Favor of Paragon Commercial Bank Dated June 25, 2008
- 10.49 EX-10.49 Unconditional Guaranty by Aristos Pharmaceuticals, Inc. In Favor of Paragon Commercial Bank Dated June 25, 2008
- 10.50 EX-10.50 Security Agreement by Aristos Pharmaceuticals, Inc. and Cornerstone Biopharma Holdings, Inc. In Favor of Paragon Commercial Bank Dated June 25, 2008
- 10.51 EX-10.51 Letter from Paragon Commercial Bank to Cornerstone Biopharma Holdings, Inc. Dated October 29, 2008
- 16.1 EX-16.1 Letter from Deloitte & Touche LLP to the Sec Dated November 5, 2008
- 16.2 EX-16.2 Letter from Hughes Pittman & Gupton, LLP to the Sec Dated November 5, 2008
- 99.1 EX-99.1 Press Release Dated November 3, 2008
- 99.2 EX-99.2 Press Release Dated November 5, 2008
- 99.3 EX-99.3 Risk Factors of the Registrant
CRTX similar filings
- 29 Dec 08 Departure of Directors or Principal Officers
- 16 Dec 08 Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
- 14 Nov 08 Changes in Registrant.s Certifying Accountant
- 5 Nov 08 Cornerstone BioPharma Announces Completion of Merger with Critical Therapeutics
- 31 Oct 08 Other Events
- 24 Oct 08 Other Events
- 21 Oct 08 Results of Operations and Financial Condition
Filing view
External links